Roche Holding AG said an experimental breast-cancer treatment will get an expedited review from US regulators after showing it helped patients live longer without the disease progressing.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
A Bristol Myers Squibb drug has got an FDA approval to treat tumors with a specific biomarker regardless of their locations ...
Treatment outcomes for breast cancer have become better over the years, but a proportion of breast cancers still recur even ...
(RTTNews) - Roche (RHHBY) said Tuesday that its whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has received 510(k) clearance from the United States Food and Drug ...
The fundraising effort was led by the Susan G. Komen foundation, SHOOK Research and Forbes, publisher of the Forbes | SHOOK ...
Germany's BioNTech SE said in a regulatory filing on Monday the U.S. Food and Drug Administration has placed a partial ...
On May 16, 2024, the FDA granted a breakthrough therapy designation to NVL-655, a novel brain-penetrant ALK-selective ...
The risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared last year, an FDA ...
Jennifer Garner and Ben Affleck's daughter Violet graduates: See the emotional reaction Peanuts by Charles Schulz We Ordered 7 Fast-Food Breakfast Sandwiches to Find the Best One 223 vs 556: What ...